The company said, “The Company is increasing full-year 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million and projected full-year 2025 Modern Oral sales to $125.0 – 130.0 million.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPB: